Reaction Details Report a problem with these data
Target
C5a anaphylatoxin chemotactic receptor 1
Ligand
BDBM50077483
Substrate
n/a
Meas. Tech.
ChEMBL_41605 (CHEMBL650558)
IC50
2630.27±n/a nM
Citation
 Finch, AM; Wong, AK; Paczkowski, NJ; Wadi, SK; Craik, DJ; Fairlie, DP; Taylor, SM Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a. J Med Chem 42:1965-74 (1999) [PubMed]  Article 
Target
Name:
C5a anaphylatoxin chemotactic receptor 1
Synonyms:
C5AR | C5AR1 | C5AR1_HUMAN | C5R1 | C5a anaphylatoxin chemotactic receptor | C5a anaphylatoxin chemotactic receptor (C5aR) | C5a-R | CD_antigen=CD88
Type:
Enzyme
Mol. Mass.:
39347.68
Organism:
Homo sapiens (Human)
Description:
P21730
Residue:
350
Sequence:
MDSFNYTTPDYGHYDDKDTLDLNTPVDKTSNTLRVPDILALVIFAVVFLVGVLGNALVVWVTAFEAKRTINAIWFLNLAVADFLSCLALPILFTSIVQHHHWPFGGAACSILPSLILLNMYASILLLATISADRFLLVFKPIWCQNFRGAGLAWIACAVAWGLALLLTIPSFLYRVVREEYFPPKVLCGVDYSHDKRRERAVAIVRLVLGFLWPLLTLTICYTFILLRTWSRRATRSTKTLKVVVAVVASFFIFWLPYQVTGIMMSFLEPSSPTFLLLKKLDSLCVSFAYINCCINPIIYVVAGQGFQGRLRKSLPSLLRNVLTEESVVRESKSFTRSTVDTMAQKTQAV
  
Inhibitor
Name:
BDBM50077483
Synonyms:
(R)-2-[(S)-2-{(R)-2-[((R)-1-{(S)-6-Amino-2-[(S)-2-((S)-2,6-diamino-hexanoylamino)-3-phenyl-propionylamino]-hexanoyl}-pyrrolidine-2-carbonyl)-amino]-3-cyclohexyl-propionylamino}-3-(1H-indol-3-yl)-propionylamino]-5-guanidino-pentanoic acid | CHEMBL2373534
Type:
Small organic molecule
Emp. Form.:
C47H69N11O7
Mol. Mass.:
900.1203
SMILES:
CN[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O |wU:40.42,54.58,2.2,wD:25.27,13.13,29.30,(.4,-4.76,;1.74,-5.54,;3.07,-4.77,;3.07,-3.23,;4.4,-2.46,;5.73,-3.23,;7.06,-2.46,;7.06,-.92,;5.73,-.15,;4.4,-.92,;4.4,-5.54,;4.4,-7.08,;5.73,-4.77,;6.5,-6.1,;5.73,-7.43,;6.5,-8.76,;5.73,-10.1,;6.5,-11.44,;5.73,-12.77,;7.83,-6.87,;7.82,-8.41,;9.15,-6.1,;9.55,-4.61,;11.09,-4.53,;11.65,-5.96,;10.45,-6.94,;11.78,-7.71,;13.11,-6.94,;11.78,-9.25,;13.11,-10.03,;14.41,-9.18,;15.77,-9.88,;16.14,-11.38,;16.72,-10.26,;18.38,-9.53,;18.03,-8.04,;17.38,-9.21,;13.87,-11.35,;15.41,-11.35,;13.1,-12.68,;14.18,-13.76,;15.68,-13.36,;16.77,-14.46,;16.35,-15.96,;17.91,-16.7,;18.99,-15.61,;20.55,-15.7,;21.4,-14.41,;20.7,-13.01,;19.15,-12.94,;18.31,-14.23,;13.78,-15.26,;12.57,-15.58,;14.86,-16.35,;14.46,-17.85,;16,-18.01,;16.63,-19.41,;18.15,-19.58,;18.78,-20.99,;20.32,-21.16,;21.21,-19.9,;20.93,-22.56,;13.55,-19.09,;14.18,-20.5,;12.03,-18.92,)|
Structure:
Search PDB for entries with ligand similarity: